Evotec SE (XTRA: EVT)
Health Care · Life Sciences Tools & Services · DE
€2.46
-11.13% today · -59.0% 1Y
Evotec SE (XTRA: EVT) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $550.90M and employs 4,461 people.
Over the last twelve months the share price has lost 59.0%, trading between 2.71 and 7.30.
Tweenvest scores Evotec SE across four factors: quality 57/100, value 68/100, growth 44/100. Its strongest factor is value.
EVT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $550.90M
- Revenue (TTM)
- $819.47M
- P/E
- —
- EPS
- -1.11
- Dividend yield
- —
- Beta (5Y)
- 1.27
- 52-week high
- €7.30
- 52-week low
- €2.71
- Avg volume (3M)
- —
- Shares outstanding
- 177.75M
- Employees
- 4,461
- Next earnings
- —
About Evotec SE
Evotec SE functions as a global collaborator, aiding the pharmaceutical and biotechnology industries in the identification and progression of novel drug candidates. The firm is actively engaged in advancing medicinal products designed to treat a diverse array of health challenges, including diabetes and its related complications, various fibrotic conditions, infectious diseases, disorders of the central nervous system, oncological conditions, pain management, inflammatory and immunological ailments, rare diseases, respiratory illnesses, and women's health concerns. Evotec SE has forged partnerships with a number of significant players in the sector, such as Bayer AG, Lilly, Chinook Therapeutics, Novo Nordisk A/S, Galapagos, Pfizer Inc., CONBA Pharmaceutical Co., Ltd., Bristol Myers Squibb Company, Zhejiang JingXin Pharmaceutical Co., Ltd, Kazia Therapeutics, Apeiron Biologics, and Takeda Pharmaceuticals. The company, initially incorporated as Evotec AG in 1993, underwent a name change to Evotec SE in April 2019 and maintains its corporate headquarters in Hamburg, Germany.
- ISIN
- DE0005664809
- Founded
- 1993
- Listed since
- Nov 12, 1999
- Exchange
- XETRA Trading Platform
- Currency
- EUR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| OmniAb, Inc.NasdaqGM: OABI | $696.42M | $4.80 | +0.21% |
| Gubra A/SCPSE: GUBRA | $696.24M | Dkr290.60 | +2.69% |
| Curiox Biosystems Co., LtdKOSDAQ: A445680 | $684.61M | ₩53,500.00 | -8.08% |
| Innova Captab LimitedNSEI: INNOVACAP | $656.33M | Rs1,110.00 | -4.97% |
| Jiangsu Hanbon Science and Technology Co., Ltd.SHSE: 688755 | $493.26M | CN¥28.88 | -4.50% |
| EirGenix Inc.TWSE: 6589 | $479.15M | NT$51.30 | +0.98% |
| SMO ClinPlus CO.,LTD.SZSE: 301257 | $475.34M | CN¥40.30 | -5.64% |
| Alpha Teknova, Inc.NasdaqGM: TKNO | $474.60M | $8.53 | -3.51% |
Figures last refreshed Oct 11, 2026.